HEALTH RESOURCE UTILIZATION OF SUBJECTS RECEIVING DENOSUMAB AND ZOLEDRONIC ACID IN A RANDOMIZED PHASE 3 TRIAL OF ADVANCED BREAST CANCER PATIENTS WITH BONE METASTASES

被引：1
|
作者：
Body, J. J. [1 ]
von Moos, R. [2 ]
Stopeck, A. [3 ]
Qian, Y. [4 ]
Braun, A. [4 ]
Chung, K. [4 ]
机构：
[1] Ctr Hosp Univ Brugmann, Brussels, Belgium
[2] Kantonsspital Graubunden, Chur, Switzerland
[3] Univ Arizona, Tucson, AZ USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72040-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A279 / A279
页数：1
相关论文
共 50 条
  • [41] Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours
    Zheng, G. Z.
    Chang, B.
    Lin, F. X.
    Xie, D.
    Hu, Q. X.
    Yu, G. Y.
    Du, S. X.
    Li, X. D.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [42] Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.
    Stopeck, A. T.
    Lipton, A.
    Martin, M.
    Body, J-J
    Paterson, A.
    Steger, G. G.
    Tonkin, K.
    de Boer, R. H.
    Fujiwara, Y.
    Yardley, D.
    Jassem, J.
    Takano, T.
    Solal-Celigny, P.
    Fan, M.
    Braun, A.
    [J]. CANCER RESEARCH, 2011, 71
  • [43] Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada
    Habib, M. J.
    Risebrough, N.
    Moore, P.
    Kendall, R.
    Li, C. M.
    Goeree, R.
    [J]. CANCER RESEARCH, 2013, 73
  • [44] Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
    Chen, Fengxia
    Pu, Feifei
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 453 - 459
  • [45] Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA).
    Smith, Matthew Raymond
    Brown, Janet Elizabeth
    Fizazi, Karim
    Klotz, Laurence
    Marx, Gavin M.
    Wang, Huei
    Warner, Douglas
    Lipton, Allan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [46] Zoledronic acid effects on pain in patients with prostate cancer and bone metastases in a randomized placebo-controlled trial
    Arbuckle, R.
    Saad, F.
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 : S33 - S33
  • [47] Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
    Ellis, Georgiana K.
    Bone, Henry G.
    Chlebowski, Rowan
    Paul, Devchand
    Spadafora, Silvana
    Smith, Judy
    Fan, Michelle
    Jun, Susie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4875 - 4882
  • [48] INCIDENCE OF ACUTE PHASE REACTIONS (APRS) IN PATIENTS WITH ADVANCED CANCER OR MULTIPLE MYELOMA (MM) AND BONE METASTASES/LESIONS FOLLOWING TREATMENT WITH DENOSUMAB OR ZOLEDRONIC ACID (ZA)
    Singh, Nina
    Campbell-Baird, Cynthia R. N.
    Polderdijk, Hans
    Harrelson, Stacey
    Buechel, Judith
    Maniar, Tap
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 337 - 337
  • [49] Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid
    Zhao, Xinmin
    Xu, Xiaofeng
    Zhang, Qunling
    Jia, Zhen
    Sun, Si
    Zhang, Jian
    Wang, Biyun
    Wang, Zhonghua
    Hu, Xichun
    [J]. BMC CANCER, 2011, 11
  • [50] Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid
    Xinmin Zhao
    Xiaofeng Xu
    Qunling Zhang
    Zhen Jia
    Si Sun
    Jian Zhang
    Biyun Wang
    Zhonghua Wang
    Xichun Hu
    [J]. BMC Cancer, 11
12345